Company / Current Assets per Share
SELLAS Life Sciences Group, Inc. Current Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.27
FY2024
5-year range
$0.15 / $7.27
FY2020-FY2024
Trend
+76.7%
vs FY2023
Sector context
#208 of 210
Health Care
What the data says
Among 210 Health Care companies, SELLAS Life Sciences Group, Inc. is in the bottom 1% for current assets per share. Current Assets per Share returned to growth in FY2024 after 3 years of decline, reaching $0.27.
Based on SEC 10-K filings.
0.27 in FY2024 with a 5-year CAGR of -39.2%.
Declined from $1.12 to $0.27 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -45.1%
- 5-Year CAGR
- -39.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 210This company $0.27 Sector average $170.65
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2024, current assets per share increased 76.7% year-over-year.
- Ranks #208 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2018.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.27 | +76.7% |
| FY2023 | $0.15 | -86.5% |
| FY2022 | $1.12 | -30.9% |
| FY2021 | $1.62 | -77.8% |
| FY2020 | $7.27 | +125.7% |
| FY2019 | $3.22 | -85.6% |
| FY2018 | $22.32 | +299.2% |
| FY2017 | $5.59 | +609.6% |
| FY2016 | $0.79 | +60.8% |
| FY2015 | $0.49 | +2.9% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026